Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • An on-site audit of the South African trial of high-dose chemotherapy for metastatic breast cancer and associated publications
    Journal Article

    Weiss, R. B.; Gill, G. G.; Hudis, C. A.
    Journal of Clinical Oncology (2001)

    Fulltext@MSK | Save
  • Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and Leukemia Group B study 8662
    Journal Article

    Hayes, D. F.; Yamauchi, H.; Broadwater, G.; Cirrincione, C. T.; Rodrigue, S. P.; Berry, D. A.; Younger, J.; Panasci, L. L.; Millard, F.; Duggan, D. B.; more...
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Modulation of Hsp90 function by ansamycins sensitizes breast cancer cells to chemotherapy-induced apoptosis in an RB- and schedule-dependent manner. See: The Biology Behind: E. A. Sausville, Combining cytotoxics and 17-allylamino, 17-demethoxygeldanamycin: Sequence and tumor biology matters. Clin. Cancer Res., 7: 2155-2158, 2001
    Journal Article

    Munster, P. N.; Basso, A.; Solit, D.; Norton, L.; Rosen, N.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells
    Journal Article

    Chiosis, G.; Timaul, M. N.; Lucas, B.; Munster, P. N.; Zheng, F. F.; Sepp-Lorenzino, L.; Rosen, N.
    Chemistry and Biology (2001)

    Fulltext@MSK | Save
  • The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells
    Journal Article

    Munster, P. N.; Troso-Sandoval, T.; Rosen, N.; Rifkind, R.; Marks, P. A.; Richon, V. M.
    Cancer Research (2001)

    Fulltext@MSK | Save
  • Farnesyl:protein transferase inhibitors as potential agents for the management of human prostate cancer
    Journal Article

    Sepp-Lorenzino, L.; Tjaden, G.; Moasser, M. M.; Timaul, N.; Ma, Z.; Kohl, N. E.; Gibbs, J. B.; Oliff, A.; Rosen, N.; Scher, H. I.
    Prostate Cancer and Prostatic Diseases (2001)

    Fulltext@MSK | Save
  • Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: A phase I trial
    Journal Article

    Gilewski, T.; Ragupathi, G.; Bhuta, S.; Williams, L. J.; Musselli, C.; Zhang, X. F.; Bencsath, K. P.; Panageas, K. S.; Chin, J.; Hudis, C. A.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2001)

    Fulltext@MSK | Save
  • Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1
    Journal Article

    Shen, Y.; Devgan, G.; Darnell, J. E. Jr; Bromberg, J. F.
    Proceedings of the National Academy of Sciences of the United States of America (2001)

    Fulltext@MSK | Save
  • Gemcitabine as single-agent therapy in the management of advanced breast cancer
    Journal Article

    Seidman, A. D.
    Oncology (Norwalk) (2001)

    Fulltext@MSK | Save
  • Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2
    Journal Article

    Slamon, D. J.; Leyland-Jones, B.; Shak, S.; Fuchs, H.; Paton, V.; Bajamonde, A.; Fleming, T.; Eiermann, W.; Wolter, J.; Pegram, M.; more...
    New England Journal of Medicine (2001)

    Fulltext@MSK | Save